Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accounts Payables: 2014-2024

Historic Accounts Payables for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $3.0 million.

  • AC Immune's Accounts Payables rose 60.30% to $3.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.0 million, marking a year-over-year increase of 60.30%. This contributed to the annual value of $3.0 million for FY2024, which is 60.30% up from last year.
  • AC Immune's Accounts Payables amounted to $3.0 million in FY2024, which was up 60.30% from $1.9 million recorded in FY2023.
  • AC Immune's Accounts Payables' 5-year high stood at $3.0 million during FY2024, with a 5-year trough of $964,322 in FY2022.
  • Its 3-year average for Accounts Payables is $2.0 million, with a median of $1.9 million in 2023.
  • As far as peak fluctuations go, AC Immune's Accounts Payables spiked by 1,583.81% in 2020, and later slumped by 56.01% in 2022.
  • Over the past 5 years, AC Immune's Accounts Payables (Yearly) stood at $2.4 million in 2020, then declined by 9.27% to $2.2 million in 2021, then slumped by 56.01% to $964,322 in 2022, then spiked by 96.29% to $1.9 million in 2023, then spiked by 60.30% to $3.0 million in 2024.